Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 64.3 | 17.6 | 23.8 | 18.1 | 28.1 | 14.3 |
| Revenue growth | 264.6% | -26.0% | | -35.5% | 96.3% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 5.8 | 6.6 | 31.5 |
| Gross profit | 64.3 | 17.6 | 23.8 | 12.3 | 21.5 | -17.2 |
| Gross margin | 100.0% | 100.0% | 100.0% | 68.0% | 76.6% | -119.8% |
| Research and development | 26.3 | 0.6 | 1.0 | | | |
| General and administrative | 10.3 | 6.6 | 0.1 | 5.8 | 6.6 | 6.5 |
| EBIT | -7.0 | -23.2 | -33.7 | -20.7 | -9.6 | -14.5 |
| EBIT margin | -10.9% | -131.3% | -141.2% | -114.5% | -34.0% | -101.5% |
| Pre-tax income | -11.3 | -27.2 | -37.4 | -26.7 | -9.8 | -40.2 |
| Income taxes | 0.0 | -0.1 | 0.2 | -0.2 | 0.0 | 0.2 |
| Tax rate | 0.3% | 0.4% | | 0.7% | 0.0% | |
| Net income | -13.1 | -30.7 | -35.2 | 0.0 | 0.0 | 0.0 |
| Net margin | -20.3% | -173.9% | -147.4% | -0.2% | 0.0% | -0.3% |
| |
| Diluted EPS | ($1.19) | ($16,591.99) | ($25,886.60) | ($15.47) | ($8.38) | ($47.30) |
| Shares outstanding (diluted) | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|